ALLO
Price
$1.91
Change
-$0.17 (-8.21%)
Updated
Dec 18, 04:59 PM (EDT)
70 days until earnings call
ZNTL
Price
$2.92
Change
-$0.22 (-7.03%)
Updated
Dec 18, 04:59 PM (EDT)
70 days until earnings call
Ad is loading...

ALLO vs ZNTL

Header iconALLO vs ZNTL Comparison
Open Charts ALLO vs ZNTLBanner chart's image
Allogene Therapeutics
Price$1.91
Change-$0.17 (-8.21%)
Volume$42.65K
CapitalizationN/A
Zentalis Pharmaceuticals
Price$2.92
Change-$0.22 (-7.03%)
Volume$17.42K
CapitalizationN/A
ALLO vs ZNTL Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLO vs. ZNTL commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and ZNTL is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ALLO: $2.07 vs. ZNTL: $3.13)
Brand notoriety: ALLO and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 92% vs. ZNTL: 96%
Market capitalization -- ALLO: $434.02M vs. ZNTL: $223.06M
ALLO [@Biotechnology] is valued at $434.02M. ZNTL’s [@Biotechnology] market capitalization is $223.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, ZNTL is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 4 TA indicator(s) are bullish while ZNTL’s TA Score has 3 bullish TA indicator(s).

  • ALLO’s TA Score: 4 bullish, 6 bearish.
  • ZNTL’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than ZNTL.

Price Growth

ALLO (@Biotechnology) experienced а -5.48% price change this week, while ZNTL (@Biotechnology) price change was -13.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

ALLO is expected to report earnings on Feb 26, 2025.

ZNTL is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALLO($434M) has a higher market cap than ZNTL($223M). ALLO YTD gains are higher at: -35.514 vs. ZNTL (-79.340). ZNTL has higher annual earnings (EBITDA): -207.96M vs. ALLO (-256.67M). ZNTL has more cash in the bank: 391M vs. ALLO (292M). ZNTL has less debt than ALLO: ZNTL (40.5M) vs ALLO (85.1M). ZNTL has higher revenues than ALLO: ZNTL (40.6M) vs ALLO (43K).
ALLOZNTLALLO / ZNTL
Capitalization434M223M195%
EBITDA-256.67M-207.96M123%
Gain YTD-35.514-79.34045%
P/E RatioN/AN/A-
Revenue43K40.6M0%
Total Cash292M391M75%
Total Debt85.1M40.5M210%
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLOZNTL
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 6 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEBCX9.90N/A
N/A
Goldman Sachs ESG Em Mkts Eq C
FDCAX43.16-0.17
-0.39%
Fidelity Capital Appreciation
JHERX20.81-0.11
-0.53%
JHancock Equity Income C
FSCHX14.39-0.08
-0.55%
Fidelity Select Chemicals
EISGX18.52-0.26
-1.38%
Eaton Vance Small-Cap I

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with MDGL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+0.97%
MDGL - ZNTL
51%
Loosely correlated
-1.58%
ORMP - ZNTL
43%
Loosely correlated
-1.67%
NRIX - ZNTL
40%
Loosely correlated
+1.78%
VCYT - ZNTL
39%
Loosely correlated
-2.52%
ALLO - ZNTL
38%
Loosely correlated
+0.49%
More